Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...

Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating ...

Let’s keep our hearts strong by giving the gift of life. Donating blood is quick, easy and can save lives. Your donation makes a real difference as every drop counts.

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by surgeon-scientists.

Platelet-rich plasma (PRP) therapy is a controversial treatment that uses a concentrated form of a person’s platelets to promote healing and regeneration in various tissues. PRP is becoming ...

A new investigation published by The BMJ highlights fresh concerns about the PLATO clinical trial, a pivotal study that led to the global approval of the anti-platelet drug ticagrelor (marketed as ...

Most human cases of bird flu in North America have been mild, a fact that’s underscored by a new study of the first 46 confirmed human H5N1 infections in the United States this year. But the ...

NIH scientists visualized how LDL binds to its receptor, identifying mutations causing cholesterol buildup and heart disease. Their findings, published in Nature, could improve personalized treatments ...

This disappoints and angers the patient community, who say the NIH should focus on ways to stop their suffering, instead of simply trying to understand why they're suffering. "It's unconscionable ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...